ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Polymyalgia Rheumatica (PMR)"

  • Abstract Number: 0858 • ACR Convergence 2024

    Baricitinib in Early Polymyalgia Rheumatica (BACHELOR Study)

    Alain SARAUX1, Guillermo CARVAJAL ALEGRIA2, Emmanuelle Dernis3, christian roux4, Christophe Richez5, Alice TISON6, Baptiste Quere7, Sandrine Jousse-Joulin8, Dewi Guellec7, Thierry Marhadou9, Patrice Kervarrec7, Divi Cornec10, Catherine Le Henaff7, Sandra Lesven7, nowak emmanuel7, Aghiles Souki7 and Valerie Devauchelle11, 1CHU Brest, Brest, France, 2CHRU de Tours, Tours, France, 3CH LE MANS, LE MANS, Pays de la Loire, France, 4rheumatology department, university Cote d'Azur, nice, France, 5Université de Bordeaux, Bordeaux, France, 6CHU de la Cavale Blanche, Brest, France, Brest, France, 7Centre Hospitalier Regional Universitaire (CHU) de Brest, Brest, France, 8cavale blanche hospital, brest, France, 9CHU Cavale Blanche, Brest, France, 10University of Brest, Brest, France, 11UBO, Brest, France

    Background/Purpose: Moderate glucocorticoids (GCs) improve nearly all cases of polymyalgia rheumatica (PMR) but related adverse events are common in senior patients.  The purpose of this…
  • Abstract Number: 1974 • ACR Convergence 2024

    The Impact of Concomitant Shoulder Osteoarthritis in Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, Robert Harrington3, David Kane4 and Richard Conway5, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3St. James's Hospital, Dublin, Dublin, Ireland, 4Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 5Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease of the shoulder and pelvic girdle. In the majority of centres, baseline shoulder radiograph forms part…
  • Abstract Number: 0859 • ACR Convergence 2024

    Incidence of Aortic Aneurysm, Dissection, or Rupture Among Patients with Polymyalgia Rheumatica and Giant Cell Arteritis

    Kylie Carlson1, Mahmut Kaymakci2, Sebastian E. Sattui3 and Michael Putman4, 1Medical College of Wisconsin, Milwaukee, WI, 2Mayo Clinic, Rochester, MN, 3University of Pittsburgh, Pittsburgh, PA, 4The Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Patients with polymyalgia rheumatica (PMR) may develop overt giant cell arteritis (GCA), but “subclinical” large vessel inflammation has also been reported in patients with…
  • Abstract Number: 1983 • ACR Convergence 2024

    Immune Checkpoint Inhibitor Associated Vasculitis and Polymyalgia Rheumatica: A Systematic Review

    Aaron Teel1, Adrian Grebowicz2, Mats Junek3, Stephanie Garner4, Tom Appleton5 and Faiza Khokhar6, 1London Health Sciences Centre, Sarnia, ON, Canada, 2Western University, London, ON, Canada, 3McMaster University, Hamilton, ON, Canada, 4University of Calgary, Calgary, AB, Canada, 5The University of Western Ontario, London, ON, Canada, 6McMaster University, St. Joseph's Hamilton, Mississauga, ON, Canada

    Background/Purpose: Immune checkpoint inhibitors (ICIs) are a class of cancer immunotherapy that have been associated with immune-related adverse events (irAEs). These include multiple rheumatic diseases…
  • Abstract Number: 0881 • ACR Convergence 2024

    Cytokine Profile of Newly Diagnosed Patients with Isolated Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, Robert Harrington3, David Kane4, Jean Dunne5, Niall conlon6 and Richard Conway7, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3St. James's Hospital, Dublin, Dublin, Ireland, 4Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 5Trinity College Dublin, Dublin, 6Trinity Colleg Dublin, Dublin, 7Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Despite polymyalgia rheumatica (PMR) being the most common inflammatory rheumatic disease in those over the age of 50 years, there remains a significant unmet…
  • Abstract Number: 2150 • ACR Convergence 2024

    Understanding Unmet Needs and Quality of Life Impact of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) Using Social Media: A Patient and Caregiver Perspective

    Pallavi Arun1, Nikita Parashar1, Sakshi Sharma1, Kanika Arora1, Vandana Padmanabhan1 and Alvaro Arjona2, 1Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 2Novartis Farmaceutica, S.A., Madrid, Madrid, Spain

    Background/Purpose: Analyzing social media conversations of patients (pts) and caregivers can be useful to understand the real-world perspectives thereby improving quality of healthcare.1 GCA and…
  • Abstract Number: 0276 • ACR Convergence 2024

    Exploring the Prevalence of Crowned Dens Syndrome in a Polymyalgia Rheumatica Veterans Affairs Patient Cohort

    Marlene Marte Furment1, Binod Kc1, Bhavya Poudyal1, Aakritee Sharma Subedi2, Mahnoor Sherazi3, Jihad Ben Gabr1, Shveta Trikha4, Brian Cooney5 and Fatme Allam5, 1SUNY Upstate Medical University, Syracuse, NY, 2SUNY Upstate University Hospital, Syracuse, 3State University of New York, Syracuse, NY, 4Syracuse VA Medical Center, Syracuse, 5Syracuse VA Medical Center, Syracuse, NY

    Background/Purpose: Crowned Dens (CD) is the radiological finding of calcium pyrophosphate dihydrate (CPPD) crystal deposition in the cruciform and alar ligaments giving the appearance of…
  • Abstract Number: 0975 • ACR Convergence 2024

    Prevalence and Management of Patients with Comorbidities and Frailty in New Onset Polymyalgia Rheumatica

    Sebastian E. Sattui1, FRANK HARTMUT DR. BUTTGEREIT2, Merav Lidar3, Kerri Ford4, Stefano Fiore5, Lita Araujo4, Timothy Beukelman6, Fenglong Xie7 and Jeffrey Curtis8, 1University of Pittsburgh, Pittsburgh, PA, 2Charité University Medicine Berlin, Berlin, Germany, 3Rheumatology Unit, Sheba Medical Center, Tel Hashomer, Israel, 4Sanofi, Cambridge, MA, 5Sanofi, Bridgewater, NJ, 6Foundation for Advancing Science, Technology, Education and Research, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL, 8The University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: PMR, a common inflammatory rheumatic disease in older adults, is primarily treated with glucocorticoids (GC). A high comorbidity burden in PMR may increase the…
  • Abstract Number: 2508 • ACR Convergence 2024

    The Impact of Lipid Profile Parameters on the Incidence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients: A Single-arm Meta-Analysis

    Nouman Shafique1, Ali Raza Khan2, Abdul Qadeer2, zaigham Shaukat2 and Rabia Iqbal2, 1AdventHealth Orlando, Orlando, FL, 2Nishtar Medical University, Multan, Punjab, Pakistan

    Background/Purpose: Cardiovascular diseases (CVD) are a significant cause of morbidity and mortality among patients with rheumatoid arthritis (RA), accounting for nearly 40% of their mortality.…
  • Abstract Number: 0310 • ACR Convergence 2024

    I-CARE Program: Interest of Multidisciplinary Systematic Screening Program for Comorbidities for Patients Suffering from Arthritis Rheumatoid DiseasE: A Real Life Study

    Amine Mouamnia, Armentieres Hospital Center, Armentieres, France

    Background/Purpose: Inflammatory and auto-immune disease are associated to comordities. Indeed, patients suffering from arthritis rheumatoid disease (ARD) such as rheumatoid arthritis (RA), polymyalgia rheumatica (PMR)…
  • Abstract Number: 1238 • ACR Convergence 2024

    Role of Patient Reported Outcomes in Predicting Disease Relapse at One Year in Those with Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, seoidin McKittrick3, Robert Harrington4, David Kane5 and Richard Conway6, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3University of Limerick, Limerick, Ireland, 4St. James's Hospital, Dublin, Dublin, Ireland, 5Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 6Trinity College Dublin, Dublin, Ireland

    Background/Purpose: One of the most significant unmet needs in the management of those with Polymyalgia Rheumatica (PMR)  is the lack of a disease stratification tool…
  • Abstract Number: 2513 • ACR Convergence 2024

    Frequency, Diagnosis, and Management of Polymyalgia Rheumatica in Germany – Database Analysis of Medical Insurance Data

    Wolfgang Schmidt1, Marco Alibone2, Paul Ludwig2, Dominik Obermüller2, Dennis Häckl3, Katrin Tönnessen4, Mirjam Fließer4, Franziska Karl4, Hien Nguyen4, Annika Boas4 and Nils Venhoff5, 1Immanuel Krankenhaus Berlin, Berlin, Germany, 2InGef-Institute for Applied Health Research Berlin GmbH, Berlin, Germany, 3WIG2 GmbH, Leipzig, Germany, 4Novartis Pharma GmbH, Nürnberg, Germany, 5Medical Center - University of Freiburg, Internal Medicine, Department of Rheumatology and Clinical Immunology, Freiburg, Germany

    Background/Purpose: To date, there is limited data on the epidemiology of polymyalgia rheumatica (PMR) in Germany. National prevalence estimates suggest only 69,000 affected individuals, which…
  • Abstract Number: 0739 • ACR Convergence 2024

    One Year Outcomes in Those with Isolated PMR Recruited via a Fast Track PMR Clinic

    Patricia Harkins1, Sharon Cowley2, Robert Harrington3, seoidin McKittrick4, David Kane5 and Richard Conway6, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3St. James's Hospital, Dublin, Dublin, Ireland, 4University of Limerick, Limerick, Ireland, 5Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 6Trinity College Dublin, Dublin, Ireland

    Background/Purpose: To date the longitudinal outcomes of those with isolated Polymyalgia Rheumatica (PMR) are poorly understood, owing largely to the fact that in the majority…
  • Abstract Number: 1318 • ACR Convergence 2024

    Patient Anxiety, Fear, and Kinesiophobia: Challenges Shared by UK Physiotherapists in Managing Polymyalgia Rheumatica – Findings from a Qualitative Study

    Anne O'Brien1, Sara Muller1, Jennifer Liddle2, Martin Thomas1 and Christian D Mallen3, 1Keele University, Keele, Staffordshire, England, United Kingdom, 2Newcastle University, Newcastle upon Tyne, United Kingdom, 3Keele University, Keele, Staffordshire, United Kingdom

    Background/Purpose: Polymyalgia Rheumatica (PMR) is the commonest rheumatic condition affecting older people. 35% of newly diagnosed patients report anxiety, (Muller et al., 2016) which, with…
  • Abstract Number: 0740 • ACR Convergence 2024

    Evaluation of an Accelerated Physical Aging Phenotype in Newly Diagnosed Patients with Polymyalgia Rheumatica

    Patricia Harkins1, Sharon Cowley2, seoidin McKittrick3, Robert Harrington4, David Kane5 and Richard Conway6, 1Trinity College Dublin, Dublin 8, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Dublin, Ireland, 3University of Limerick, Limerick, Ireland, 4St. James's Hospital, Dublin, Dublin, Ireland, 5Tallaght University Hospital & Trinity College Dublin, D24, Ireland, 6Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Polymyalgia Rheumatica (PMR) is the most common inflammatory rheumatic disease in older adults, and aging has been postulated to be central to its pathophysiology.…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology